Intervention Review

You have free access to this content

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

  1. Francesco Angelico1,*,
  2. Cesare Alessandri2,
  3. Maria Del Ben2,
  4. Flavio Lirussi3

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 30 APR 2013

Assessed as up-to-date: 13 NOV 2006

DOI: 10.1002/14651858.CD005166.pub3


How to Cite

Angelico F, Alessandri C, Del Ben M, Lirussi F. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD005166. DOI: 10.1002/14651858.CD005166.pub3.

Author Information

  1. 1

    IV Divisione di Clinica Medica - Policlinico Umberto 1, Dipartimento di Medicina Sperimentale e Patologia, Rome, Italy

  2. 2

    University La Sapienza, Rome, Italy, Experimental Medicine and Pathology, Rome, Italy

  3. 3

    WHO European Office for Investment for Health and Development, Venice, Italy

*Francesco Angelico, Dipartimento di Medicina Sperimentale e Patologia, IV Divisione di Clinica Medica - Policlinico Umberto 1, Centro per l'Atero-trombosi, Università La Sapienza, viale del Policlinico 155, Rome, 00161, Italy. francesco.angelico@uniroma1.it.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 30 APR 2013

SEARCH